KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Research & Development: 2009-2024

Historic Research & Development for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $255.8 million.

  • Cme Group's Research & Development rose 7.21% to $71.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.7 million, marking a year-over-year increase of 10.10%. This contributed to the annual value of $255.8 million for FY2024, which is 16.96% up from last year.
  • Latest data reveals that Cme Group reported Research & Development of $255.8 million as of FY2024, which was up 16.96% from $218.7 million recorded in FY2023.
  • In the past 5 years, Cme Group's Research & Development ranged from a high of $255.8 million in FY2024 and a low of $188.6 million during FY2022.
  • In the last 3 years, Cme Group's Research & Development had a median value of $218.7 million in 2023 and averaged $221.0 million.
  • Per our database at Business Quant, Cme Group's Research & Development decreased by 2.97% in 2021 and then climbed by 16.96% in 2024.
  • Yearly analysis of 5 years shows Cme Group's Research & Development stood at $198.5 million in 2020, then declined by 2.97% to $192.6 million in 2021, then declined by 2.08% to $188.6 million in 2022, then increased by 15.96% to $218.7 million in 2023, then increased by 16.96% to $255.8 million in 2024.